The effect of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials Article

Industry Collaboration International Collaboration

cited authors

  • Leiter, Lawrence A.; Bain, Stephen C.; Bhatt, Deepak L.; Buse, John B.; Mazer, C. David; Pratley, Richard E.; Rasmussen, Soren; Ripa, Maria Sejersten; Vrazic, Hrvoje; Verma, Subodh

authors

Publication Date

  • June 3, 2020

webpage

published in

category

keywords

  • MACE
  • blood pressure
  • cardiovascular
  • liraglutide
  • semaglutide

start page

  • 1690

end page

  • 1695

volume

  • 22

issue

  • 9